Status | Study |
Terminated |
Study Name: Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA Condition: Mucopolysaccharidosis Type IVA Date: 2012-11-21 |
Completed |
Study Name: Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease Condition: Mucopolysaccharidosis IV A Mucopolysaccharidosis VI Date: 2012-10-12 Interventions: Other: Enzyme testing Leukocyte activity measurement of Arylsulfatase B and N acetyl galactosamine 6 sul |
Terminated |
Study Name: Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation Condition: Mucopolysaccharidosis IVA Morquio A Syndrome Date: 2012-09-17 Interventions: Drug: BMN 110 Drug will be delivered through a 4 hour (approximate) IV infusion at a dosage amount of 2. |
Terminated |
Study Name: Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome Condition: Mucopolysaccharidosis IVA Morquio A Syndrome Date: 2012-05-24 Interventions: Drug: BMN 110 Weekly IV infusi |
Completed |
Study Name: Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: Mucopolysaccharidosis IVA Morquio A Syndrome Date: 2011-12-22 Interventions: Drug: BMN 110 Patients will receive intravenous (IV) infusions of study drug at a dose of 2.0 mg/kg/wk o |
Completed |
Study Name: Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: Mucopolysaccharidosis IV A Morquio A Synd Date: 2011-08-08 Interventions: Drug: BMN 110 - Weekly |
Recruiting |
Study Name: Longitudinal Studies of Brain Structure and Function in MPS Disorders Condition: Mucopolysaccharidosis Type I Mucopolysaccharidosis Type II Date: 2011-08-02 |
Completed |
Study Name: A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: MPS IV A Date: 2011-01-10 Interventions: Drug: BMN 110 Weekly BMN 110 W |
Terminated |
Study Name: A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: MPS IV A Mucopolysaccharidosis IVA Date: 2010-10-28 Interventions: Drug: BMN 110 Patients will receive an intravenous infusion of BMN110 at 2.0mg/kg/week, over a period of |
Completed |
Study Name: A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA Condition: MPS IV A Date: 2009-04-10 Interventions: Drug: BMN 110 Subjects will receive a weekly 4- to 5-hour |